New combo TB regimen proves potent and effective in Phase-II trials
Combination testing paradigm would reduce novel regimen testing time from decades to years
Early clinical trial results are promising for a new combination tuberculosis (TB) drug therapy that is proving potent and could reduce treatment time to just four months for patients with drug-sensitive TB as well as many drug-resistant strains…